Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120

Title
Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120
Authors
Keywords
AML, Isocitrate dehydrogenase mutation, Myeloid maturation, Retinoic acid syndrome, Targeted therapy
Journal
Clinical Lymphoma Myeloma & Leukemia
Volume 16, Issue 8, Pages 460-465
Publisher
Elsevier BV
Online
2016-05-06
DOI
10.1016/j.clml.2016.04.006

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search